The same variant also raised odds of nausea and vomiting, and tirzepatide users carrying two variants had 14.8 times the odds of vomiting, researchers report.
Recap by typeshit. Full story at health.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Yale Medicine says 5% to 10% of people on GLP-1 weight loss drugs see little result, and points to diet as one factor that can blunt the effect.
24:26
A doctor's explainer sorting peptides into eight broad categories. An evergreen overview for anyone still learning the basics.
Industry executives say India's contract drug makers are moving past cheap small molecules into more complex products, including peptides.
A guide covers who qualifies for the lower price, how to bring it up with a doctor, and delivery options that cut costs further.
Loading…